Treatment of early breast cancer

Minerva Endocrinologica

Volumn 34, Issue 4, 2009, Pages 311-324

  Rao, R ^a   Wiechmann, L ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Breast neoplasms; Early diagnosis; Surgical procedures, operative; Therapeutics

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; EARLY CANCER; ECHOMAMMOGRAPHY; EVENT FREE SURVIVAL; HEALTH CARE COST; HUMAN; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; NEEDLE BIOPSY; NIPPLE SPARING MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARTIAL BODY RADIATION; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE; SKIN SPARING MASTECTOMY; STEREOTACTIC BIOPSY; ADJUVANT THERAPY; BREAST RECONSTRUCTION; BREAST TUMOR; CARCINOMA; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; LYMPHADENECTOMY; METHODOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; STATISTICS; SURVIVAL;

BREAST NEOPLASMS; CARCINOMA; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MAMMAPLASTY; MASTECTOMY; MULTICENTER STUDIES AS TOPIC; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 77952293953     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Robinson JO. Treatment of breast cancer through the ages. Am J Surg 1986;151:317-33.
2. Halsted WS. I. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907;46:1-19.
3. Maddox WA, Carpenter JT, Jr., Laws HL, Soong SJ, Cloud G, Urist MM et al. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg 1983;198:207-12.
4. Fisher B. Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 1977;40:574-87. (Pubitemid 8175484)
5. Hellman S, Harris JR. The appropriate breast cancer paradigm. Cancer Res 1987;47:339-42.
6. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11. (Pubitemid 11071189)
7. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32. (Pubitemid 35176241)
8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: 1233-41. (Pubitemid 35176242)
9. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567-75.
10. Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-69. (Pubitemid 36722306)
11. Minkowitz S, Moskowitz R, Khafif RA, Alderete MN. TRU-CUT needle biopsy of the breast. An analysis of its specificity and sensitivity. Cancer 1986;57:320-3.
12. Wallace JE, Sayler C, McDowell NG, Moseley HS. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg 1996;171:471-3. (Pubitemid 26189767)
13. Fajardo LL, DeAngelis GA. The role of stereotactic biopsy in abnormal mammograms. Surg Oncol Clin N Am 1997;6:285-99.
14. Liberman L, Sama MP. Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2000;175:53-8. (Pubitemid 30415536)
15. Frazee RC, Roberts JW, Symmonds RE, Snyder SK, Hendricks JC, Smith RW et al. Open versus stereotactic breast biopsy. Am J Surg 1996;172:491-3;discussion 94-5.
16. Fahy BN, Bold RJ, Schneider PD, Khatri V, Goodnight JE, Jr. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions;discussion 994-5. Arch Surg 2001;136:990-4.
17. Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997;202:849-54. (Pubitemid 27093465)
18. Lindfors KK, Rosenquist CJ. Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology 1994;190:217-22.
19. Morrow M, Venta L, Stinson T, Bennett C. Prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 2001;233:537-41. (Pubitemid 32234952)
20. Golub RM, Bennett CL, Stinson T, Venta L, Morrow M. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol 2004;22:2430-7. (Pubitemid 41115401)
21. Baines CJ, Miller AB, Wall C, McFarlane DV, Simor IS, Jong R et al. Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology 1986;160:295-8. (Pubitemid 16070629)
22. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Velez M et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151-63.
23. Jensen A, Vejborg I, Severinsen N, Nielsen S, Rank F, Mikkelsen GJ et al. Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer 2006;119:183-91.
24. Thompson M, Henry-Tillman R, Margulies A, Thostenson J, Bryant-Smith G, Fincher R et al. Hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol 2007;14:148-56.
25. Layeequr Rahman R, Crawford S, Larkin A, Quinlan R. Superiority of sonographic hematoma guided resection of mammogram only visible breast cancer: wire localization should be an exception-not the rule. Ann Surg Oncol 2007;14:2228-32.
26. Layeequr Rahman R, Iuanow E, Crawford S, Quinlan R. Sonographic hematoma-guided vs wire-localized lumpectomy for breast cancer: a comparison of margins and volume of resection. Arch Surg 2007;142:343-6.
27. Crystal P, Strano SD, Shcharynski S, Koretz MJ. Using sonography to screen women with mammographically dense breasts. AJR Am J Roentgenol 2003;181:177-82.
28. Buchberger W, Niehoff A, Obrist P, DeKoekkoek-Doll P, Dunser M. Clinically and mammographicaUy occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 2000;21:325-36.
29. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225:165-75.
30. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound. A retrospective review. Cancer 1995;76:626-30.
31. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 2001;221:641-9.
32. Leconte I, Feger C, Galant C, Berlière M, Berg BV, D'Hoore W et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol. 2003;180:1675-9. (Pubitemid 36687107)
33. Turner DA. Nuclear magnetic resonance in oncology. Semin Nucl Med 1985;15:210-23.
34. Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Kopans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002;8:145-8.
35. Schelfout K, Van Goethem M, Kersschot E, Colpaert C, Schelfhout AM, Leyman P et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004;30:501-7.
36. Wright H, Listinsky J, Rim A, Chellman-Jeffers M, Patrick R, Rybicki L et al. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. Am J Surg 2005;190:572-5. (Pubitemid 41306078)
37. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20:3413-23.
38. Drew PJ, Harvey I, Hanby A, Brown S, Olivier C, Napp V et al. The UK NIHR multicentre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer. Cancer Research 2009;69:75s-75s.
39. Locker GY, Sainsbury JR, Cuzick J. Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Cancer 2004;101:735-40.
40. Tuttle TM, Jarosek S, Habermann EB, Arlington A, Abraham A, Morris TJ et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 2009;27:1362-7.
41. Punglia RS, Morrow M, Winer EP, Harris JR. Local therapy and survival in breast cancer. N Engl J Med 2007;356:2399-405.
42. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008;26:2373-8.
43. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
44. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005;241:629-39. (Pubitemid 40397311)
45. Silverstein MJ, Buchanan C. Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status. Breast 2003;12:457-71. (Pubitemid 38008660)
46. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93.
47. Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002;52:277-300. (Pubitemid 35345499)
48. Gilleard O, Goodman A, Cooper M, Davies M, Dunn J. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ. World J Surg Oncol 2008;6:61.
49. MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R et al. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer 2007;110:2648-53. (Pubitemid 350250333)
50. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52. (Pubitemid 28135585)
51. Keynes G. The place of radium in the treatment of cancer of the breast. Ann Surg 1937;106:619-30.
52. Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg 2009;198:83-91.
53. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001;37:2178-83.
54. Cochrane RA, Valasiadou P, Wilson AR, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90:1505-9.
55. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31:753-64.
56. McCulley SJ, Macmillan RD. Planning and use of therapeutic mammoplasty-Nottingham approach. Br J Plast Surg 2005;58:889-901.
57. Asgeirsson KS, McCulley SJ, Pinder SE, Macmillan RD. Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. Eur J Cancer 2003;39:2462-9.
58. Benson JR, Querci della Rovere G. Towards a scientific basis for oncoplastic breast surgery. Eur J Surg Oncol 2003;29:629.
59. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55.
60. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
61. Behranwala KA, Dua RS, Ross GM, Ward A, A'Hern R, Gui GP. The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 2006;59:1043-51. (Pubitemid 44391162)
62. Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN et al. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 2005;28:485-94.
63. Freeman BS. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull 1962;30:676-82.
64. Morimoto T, Komaki K, Inui K, Sasa M, Ooshimo K, Miki H et al. Involvement of nipple and areola in early breast cancer. Cancer 1985;55:2459-63. (Pubitemid 15115198)
65. Laronga C, Kemp B, Johnston D, Robb GL, Singletary SE. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol 1999;6:609-13. (Pubitemid 29428803)
66. Petit JY, Veronesi U, Orecchia R, Rey P, Martella S, Didier F et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat 2009;117:333-8.
67. Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol 2008;34:143-8.
68. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negativ breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007;8:881-8.
69. Posther KE, McCall LM, Blumencranz PW, Burak WE Jr, Beitsch PD, Hansen NM et al. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 2005;242:593-9;discussion 99-602.
70. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-50.
71. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7. (Pubitemid 27270119)
72. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
73. Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
74. Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008;95:302-9.
75. Park J, Fey JV, Naik AM, Borgen PI, Van Zee KJ, Cody HS, 3rd. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 2007;245:462-8.
76. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986;158:325-6. (Pubitemid 16160589)
77. Pamilo M, Soiva M, Lavast EM. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 1989;8:115-20. (Pubitemid 19083897)
78. Tate JJ, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I. Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1989;15:139-41. (Pubitemid 19114096)
79. Verbanck J, Vandewiele I, De Winter H, Tytgat J, Van Aelst F, Tanghe W. Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: a prospective study in 144 consecutive patients. J Clin Ultrasound 1997;25:53-6. (Pubitemid 27058463)
80. van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KG, Peterse JL, Rutgers EJ et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006;13:31-5.
81. Topal U, Punar S, Tasdelen I, Adim SB. Role of ultra-sound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. Eur J Radiol 2005;56:382-5. (Pubitemid 41659389)
82. Somasundar P, Gass J, Steinhoff M, Koeliker S, Dizon D, Cady B et al. Role of ultrasound-guided axillary fine-needle aspiration in the management of invasive breast cancer. Am J Surg 2006;192:458-61. (Pubitemid 44362982)
83. Rao R, Lilley L, Andrews V, Radford L, Ulissey M. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy. Ann Surg Oncol 2009;16:1170-5.
84. Podkrajsek M, Music MM, Kadivec M, Zgajnar J, Besic N, Pogacnik A et al. Role of ultrasound in the preoperative staging of patients with breast cancer. Eur Radiol 2005;15:1044-50.
85. Oruwari JU, Chung MA, Koelliker S, Steinhoff MM, Cady B. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Am J Surg 2002;184:307-9.
86. Nori J, Vanzi E, Bazzocchi M, Bufalini FN, Distante V, Branconi F et al. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg 2007;193:16-20. (Pubitemid 44937150)
87. Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Van Der Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 2003;39: 170-4.
88. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002;95:982-8.
89. Damera A, Evans AJ, Cornford EJ, Wilson AR, Burrell HC, James JJ, et al. Diagnosis of axiUary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 2003;89:1310-3.
90. Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C et al. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat 2007;103:85-91.
91. Britton PD, Provenzano E, Barter S, Gaskarth M, Goud A, Moyle P et al . Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied? Breast 2009;18:13-6.
92. Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK et al. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg 2007;194:450-5.
93. Bonnema J, van Geel AN, van Ooijen B, Mali SP, Tjiam SL, Henzen-Logmans SC et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 1997;21:270-4.
94. Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 2003;10:1025-30.
95. Altomare V, Guerriero G, Carino R, Battista C, Primavera A, Altomare A et al. Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the Literature. Surg Today 2007;37:735-9.
96. Alkuwari E, Auger M. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation. Cancer 2008;114:89-93.
97. Genta F, Zanon E, Camanni M, Deltetto F, Drogo M, Gallo R et al. Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 2007;31:1155-63.